Innocoll AG (INNL) Posts Quarterly Earnings Results, Misses Estimates By $0.03 EPS
Innocoll AG (NASDAQ:INNL) announced its quarterly earnings data on Tuesday. The specialty pharmaceutical company reported ($0.51) earnings per share for the quarter, missing the consensus estimate of ($0.48) by $0.03. Innocoll AG had a negative net margin of 1,139.95% and a negative return on equity of 1,226.28%.
Innocoll AG (NASDAQ:INNL) opened at 2.73 on Wednesday. The stock’s 50 day moving average is $4.70 and its 200 day moving average is $6.10. Innocoll AG has a one year low of $2.20 and a one year high of $12.94. The firm’s market cap is $66.48 million.
Several equities analysts have recently weighed in on the stock. JMP Securities reiterated a “buy” rating on shares of Innocoll AG in a report on Sunday, November 6th. Zacks Investment Research upgraded shares of Innocoll AG from a “hold” rating to a “buy” rating and set a $3.75 price objective on the stock in a report on Wednesday, November 9th. Finally, FBR & Co dropped their price objective on shares of Innocoll AG from $18.00 to $13.00 and set an “outperform” rating on the stock in a report on Friday, November 4th.
ILLEGAL ACTIVITY NOTICE: This article was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this article on another domain, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The correct version of this article can be accessed at https://www.thecerbatgem.com/2016/11/23/innocoll-ag-innl-posts-quarterly-earnings-results-misses-estimates-by-0-03-eps.html.
About Innocoll AG
Innocoll Holdings Public Limited Company is a commercial-stage specialty pharmaceutical and medical device company with late-stage development programs. The Company operates through the segment of manufacture and sale of collagen-based pharmaceutical products. It utilizes collagen-based technology platform to develop its biodegradable and bioresorbable products and product candidates, which can be broken down by the body without the need for surgical removal or applied topically.
Receive News & Stock Ratings for Innocoll AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innocoll AG and related stocks with our FREE daily email newsletter.